Sterility Issue Prompts Recall of Injectable Antiepileptic Drug By Brian Park, PharmD Publish Date November 22, 2021
FDA Adds Restrictions, Updates Labeling for Breast Implants By Brian Park, PharmD Publish Date October 28, 2021
Pepaxto Withdrawn from US Market Following OCEAN Trial Results By Brian Park, PharmD Publish Date October 22, 2021
Cubicin Recall Initiated Due to Glass Particles Found in Vial By Brian Park, PharmD Publish Date October 21, 2021
Antihypertensive Meds Recalled Due to Nitrosamine Impurity By Brian Park, PharmD Publish Date October 14, 2021
FDA: Needle-Free Devices Should Not Be Used to Inject Dermal Fillers By Diana Ernst, RPh Publish Date October 12, 2021
Lotrimin, Tinactin Spray Products Recalled Due to Presence of Benzene By Brian Park, PharmD Publish Date October 4, 2021
FDA: Risk of LAAO Implant-Related Adverse Events May Be Higher for Women By Diana Ernst, RPh Publish Date September 28, 2021
Glucagon Emergency Kit Recalled Due to Loss of Potency By Brian Park, PharmD Publish Date September 27, 2021
Pfizer Expands Recall to All Lots of Chantix Due to Nitrosamine Impurity By Brian Park, PharmD Publish Date September 17, 2021
Ruzurgi Tablets Recalled Due to Yeast, Mold, Bacterial Contamination By Brian Park, PharmD Publish Date September 14, 2021
Warning Letters Sent to Companies Selling Supplements Claiming to Treat Diabetes By Brian Park, PharmD Publish Date September 10, 2021
Lidocaine HCI Topical Solution Recalled Due to Super Potency By Brian Park, PharmD Publish Date September 8, 2021
Recall of Amino Acid Injection Initiated Due to Visible Particulate Matter By Diana Ernst, RPh Publish Date September 7, 2021
FDA: New Warnings and Limitations Set for Certain JAK Inhibitors By Brian Park, PharmD Publish Date September 1, 2021
Pfizer Expands Chantix Recall Due to Nitrosamine Impurity By Brian Park, PharmD Publish Date August 19, 2021
Sodium Bicarbonate Injection Recalled Due to Microbial Contamination By Brian Park, PharmD Publish Date August 11, 2021
Treatment for Pneumocystis Pneumonia Recalled Due to Temperature Control Issue By Diana Ernst, RPh Publish Date August 9, 2021
Oteseconazole Gets Priority Review for Recurrent Vulvovaginal Candidiasis By Brian Park, PharmD Publish Date July 28, 2021
FDA: Increased Risk of Death Reported in Pepaxto Confirmatory Trial By Brian Park, PharmD Publish Date July 28, 2021
FDA Takes Steps to Maintain Supply of Smoking Cessation Therapy By Diana Ernst, RPh Publish Date July 19, 2021
Presence of Benzene Prompts Recall of Neutrogena, Aveeno Sunscreens By Brian Park, PharmD Publish Date July 15, 2021
Neulasta Ad Claims Misleading, May Undermine Biosimilar Use, Says FDA By Diana Ernst, RPh Publish Date July 15, 2021
Cholesterol Management Supplement Found to Contain Undeclared Rx Ingredient By Diana Ernst, RPh Publish Date July 12, 2021
FDA Issues Safety Alert Regarding Use of Hydroxyethyl Starch Products By Brian Park, PharmD Publish Date July 8, 2021
Risk of Falsely Low Results Prompts Recall of Lead Tests By Brian Park, PharmD Publish Date July 7, 2021
Chantix Recalled, Distribution Halted Over Nitrosamine Impurity By Brian Park, PharmD Publish Date July 6, 2021
Presence of Particulate Prompts Recall of Topotecan Injection By Brian Park, PharmD Publish Date July 2, 2021
FDA: Systemic Side Effects Reported After Hand Sanitizer Application By Brian Park, PharmD Publish Date June 17, 2021
FDA Cracks Down on Companies Selling Unproven Infertility Supplements By Diana Ernst, RPh Publish Date May 27, 2021
FDA: Ocaliva Should Not Be Used in PBC Patients With Advanced Cirrhosis By Brian Park, PharmD Publish Date May 26, 2021
Weight Loss Supplement Recalled Due to Presence of Stimulant By Brian Park, PharmD Publish Date May 19, 2021
Class I Recall Issued for HeartWare HVAD System Instructions for Use, Patient Manual By Diana Ernst, RPh Publish Date May 12, 2021
Insulin Product Samples Recalled Due to Improper Storage Temperature Conditions By Brian Park, PharmD Publish Date May 11, 2021
Certain Lots of NP Thyroid Recalled Due to Subpotent Tablets By Brian Park, PharmD Publish Date April 30, 2021
Medtronic Stent Graft System Recalled Due to Fractures, Endoleaks By Diana Ernst, RPh Publish Date April 12, 2021
FDA: Risk of Arrhythmias With Lamotrigine in Patients With Heart Disease By Brian Park, PharmD Publish Date April 1, 2021
Antihypertensive Medication Recalled Due to Label Mix-Up By Diana Ernst, RPh Publish Date March 30, 2021
Crystallization Complaints Prompt Recall of Injectable Antiviral By Diana Ernst, RPh Publish Date March 30, 2021
FDA: Abuse/Misuse of OTC Nasal Decongestant Can Lead to Major Health Complications By Diana Ernst, RPh Publish Date March 25, 2021
FDA Cracks Down on Companies Selling Unapproved CBD Products By Diana Ernst, RPh Publish Date March 23, 2021
Possible Sterility Breach Prompts Recall of Phenylephrine Hydrochloride Injection By Brian Park, PharmD Publish Date March 12, 2021
FDA: Certain Factors May Affect Pulse Oximeter Accuracy By Brian Park, PharmD Publish Date February 22, 2021
Dry Mouth Spray Recalled Due to Possible Microbial Contamination By Brian Park, PharmD Publish Date February 19, 2021
Packaging Error Prompts Recall of Enoxaparin Sodium Injection By Brian Park, PharmD Publish Date February 9, 2021
FDA: Compounded Remdesivir Products Should Not Be Used By Diana Ernst, RPh Publish Date February 8, 2021
Neuromuscular Blocker Recalled Due to Label Mix-Up By Brian Park, PharmD Publish Date January 28, 2021
Potential Med Errors Prompt FDA Action on Vinca Alkaloid Labeling By Diana Ernst, RPh Publish Date January 19, 2021
Injectable NSAID Recalled Due to Particulate Matter Found in Vials By Brian Park, PharmD Publish Date January 11, 2021
FDA: SARS-CoV-2 Mutations May Impact Molecular Tests By Brian Park, PharmD Publish Date January 8, 2021
False Results Possible With Curative SARS-CoV-2 Test, Says FDA By Brian Park, PharmD Publish Date January 5, 2021
FDA Strengthens REMS for Transmucosal Immediate-Release Fentanyl Products By Brian Park, PharmD Publish Date December 28, 2020
Counterfeit HIV Drug Identified in Three US Pharmacies By Diana Ernst, RPh Publish Date December 28, 2020
No Significant Difference Between Sitagliptin, Placebo in Pediatric T2D Trials By Diana Ernst, RPh Publish Date December 7, 2020
FDA: Risk of Inadvertent Intrathecal Administration of Tranexamic Acid Injection By Brian Park, PharmD Publish Date December 4, 2020
Recall: Lidocaine Identified in Dexmedetomidine Vials By Diana Ernst, RPh Publish Date November 20, 2020
Possible Microbial Contamination Prompts Recall of Oral Rinse By Brian Park, PharmD Publish Date October 29, 2020
FDA: NSAID Use Should Be Avoided in Pregnancy Even Sooner Than 30 Weeks By Brian Park, PharmD Publish Date October 16, 2020
Insulin Pens Should Be Dispensed in Original Packaging, Says FDA By Diana Ernst, RPh Publish Date October 16, 2020
FDA: Diphenhydramine Overdoses Linked to New Social Media Challenge By Brian Park, PharmD Publish Date September 25, 2020
FDA Requires Boxed Warning Update for Benzodiazepines By Brian Park, PharmD Publish Date September 24, 2020
Thyroid Medication Recalled Due to Subpotent Tablets By Brian Park, PharmD Publish Date September 21, 2020
FDA Cracks Down on Websites Illegally Selling Opioids By Brian Park, PharmD Publish Date September 11, 2020
FDA: Efficacy, Safety Concerns With Breast Cancer Combo Therapy By Brian Park, PharmD Publish Date September 10, 2020
FDA: Stimulation Trial Should Be Performed Before Implanting SCS for Pain By Brian Park, PharmD Publish Date September 4, 2020
